Arkolith/Insider Trading/MTCR/Form 4

venBio Global Strategic GP, L.P.

10% OwnerMetacrine, Inc. (MTCR) · full profile →Form 4 · filed Oct 26, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$929K
Net Open-Market Flow
-$929K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 25, 2021Sell(S)541K$1.49$806K2.4M
Oct 22, 2021Sell(S)75K$1.64$123K3.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-21-018722) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML